Truvestments Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Buy |
9,959
+101
| +1% | +$22.4K | 0.39% | 65 |
|
|
2025
Q4 | $2.25M | Sell |
9,858
-381
| -4% | -$86.8K | 0.41% | 71 |
|
|
2025
Q3 | $2.37M | Sell |
10,239
-2,804
| -21% | -$571K | 0.43% | 70 |
|
|
2025
Q2 | $2.42M | Sell |
13,043
-759
| -5% | -$141K | 0.48% | 62 |
|
|
2025
Q1 | $2.89M | Sell |
13,802
-9,377
| -40% | -$1.82M | 0.63% | 57 |
|
|
2024
Q4 | $4.12M | Buy |
23,179
+1,358
| +6% | +$250K | 1.06% | 13 |
|
|
2024
Q3 | $4.31M | Buy |
21,821
+2,082
| +11% | +$389K | 1.16% | 11 |
|
|
2024
Q2 | $3.39M | Buy |
19,739
+214
| +1% | +$35.4K | 1.35% | 11 |
|
|
2024
Q1 | $3.56M | Buy |
19,525
+6,317
| +48% | +$1.09M | 1.37% | 11 |
|
|
2023
Q4 | $2.05M | Buy |
13,208
+1,481
| +13% | +$216K | 0.92% | 36 |
|
|
2023
Q3 | $1.75M | Buy |
11,727
+490
| +4% | +$71.9K | 0.91% | 41 |
|
|
2023
Q2 | $1.51M | Buy |
11,237
+928
| +9% | +$136K | 0.75% | 54 |
|
|
2023
Q1 | $1.64M | Sell |
10,309
-1,292
| -11% | -$198K | 0.88% | 50 |
|
|
2022
Q4 | $1.87M | Sell |
11,601
-11,620
| -50% | -$1.78M | 1.06% | 31 |
|
|
2022
Q3 | $3.12M | Buy |
23,221
+1,041
| +5% | +$149K | 1.97% | 8 |
|
|
2022
Q2 | $3.4M | Buy |
22,180
+196
| +0.9% | +$29.9K | 1.99% | 7 |
|
|
2022
Q1 | $3.56M | Sell |
21,984
-8
| -0% | -$1.16K | 1.95% | 9 |
|
|
2021
Q4 | $2.98M | Buy |
21,992
+495
| +2% | +$58.5K | 1.5% | 12 |
|
|
2021
Q3 | $2.32M | Buy |
21,497
+857
| +4% | +$97.9K | 1.28% | 20 |
|
|
2021
Q2 | $2.33M | Buy |
20,640
+1,217
| +6% | +$137K | 1.28% | 20 |
|
|
2021
Q1 | $2.1M | Buy |
19,423
+2,117
| +12% | +$226K | 1.19% | 15 |
|
|
2020
Q4 | $1.85M | Buy |
17,306
+698
| +4% | +$67.1K | 1.29% | 11 |
|
|
2020
Q3 | $1.45M | Sell |
16,608
-2,730
| -14% | -$257K | 1.31% | 14 |
|
|
2020
Q2 | $1.9M | Sell |
19,338
-1,891
| -9% | -$166K | 1.93% | 8 |
|
|
2020
Q1 | $1.62M | Buy |
21,229
+511
| +2% | +$43.5K | 2.05% | 7 |
|
|
2019
Q4 | $1.83M | Buy |
20,718
+1,152
| +6% | +$95.6K | 1.27% | 23 |
|
|
2019
Q3 | $1.48M | Buy |
19,566
+4,723
| +32% | +$324K | 0.97% | 28 |
|
|
2019
Q2 | $1.08M | Buy |
14,843
+7,595
| +105% | +$597K | 0.73% | 38 |
|
|
2019
Q1 | $584K | Buy |
+7,248
| New | +$593K | 0.45% | 63 |
|
|
2018
Q3 | $1.37M | Buy |
14,512
+463
| +3% | +$43.9K | 0.66% | 38 |
|
|
2018
Q2 | $1.3M | Buy |
+14,049
| New | +$1.37M | 0.82% | 33 |
|
Other funds holding ABBV
VCM
VPM
Truvestments Capital's ABBV Position: Q1 2026 in Review
Truvestments Capital increased its AbbVie (ABBV) stake by 1% in Q1 2026, buying an estimated $22.4K and bringing the position to 9,959 shares worth $2.17M. The position accounts for 0.39% of the portfolio, ranked #65.
Truvestments Capital first reported a position in ABBV in Q2 2018 and has held it in 31 quarters since. The position peaked at $4.31M in Q3 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Truvestments Capital held 9,959 shares of AbbVie worth $2.17M as of Q1 2026.
- Truvestments Capital bought 101 AbbVie shares in Q1 2026, an estimated $22.4K.
- AbbVie made up 0.39% of Truvestments Capital's portfolio in Q1 2026, its #65 holding.
- Truvestments Capital first reported a position in AbbVie in Q2 2018 and has held it in 31 quarters since.
- Truvestments Capital's AbbVie position peaked at $4.31M in Q3 2024.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.